Trial Profile
Randomized Controlled Trial of Losartan for Patients With COVID-19 Not Requiring Hospitalization
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 May 2022
Price :
$35
*
At a glance
- Drugs Losartan (Primary)
- Indications COVID-19 respiratory infection
- Focus Therapeutic Use
- 12 Feb 2021 Status changed from active, no longer recruiting to completed.
- 13 Nov 2020 Status changed from recruiting to active, no longer recruiting.
- 09 Apr 2020 Planned number of patients changed from 516 to 580.